These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32724)

  • 21. [Clinical experiences with the new-generation anxiolytic agent cloxazolam--a double-blind study].
    Zmorski T; Fischer-Cornelssen KA
    Schweiz Rundsch Med Prax; 1985 Jul; 74(27):728-34. PubMed ID: 2862687
    [No Abstract]   [Full Text] [Related]  

  • 22. Recent advances in anxiolytic therapy.
    Rickels K
    J Clin Psychiatry; 1981 Nov; 42(11 Pt 2):40-4. PubMed ID: 6120938
    [No Abstract]   [Full Text] [Related]  

  • 23. Alprazolam in clinically anxious patients with depressed mood.
    Aden GC
    J Clin Psychiatry; 1983 Jan; 44(1):22-4. PubMed ID: 6130082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double blind comparison of ketazolam given once each day with diazepam given in divided doses and placebo in the treatment of anxiety.
    Br J Clin Pract; 1980 Apr; 34(4):107-13. PubMed ID: 6104979
    [No Abstract]   [Full Text] [Related]  

  • 25. [Double blind comparative clinical evaluation of a new anxiolytic agent, Zami-905: propazepam].
    Carbonell Masía DC; Calvé Pérez A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1976; 4(6):377-86. PubMed ID: 19933
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative efficacy of tofisopam and placebo.
    Goldberg HL; Finnerty RJ
    Am J Psychiatry; 1979 Feb; 136(2):196-9. PubMed ID: 32777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan.
    Inada T; Nozaki S; Inagaki A; Furukawa TA
    Hum Psychopharmacol; 2003 Aug; 18(6):483-7. PubMed ID: 12923829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical comparison between alprazolam and lorazepam. A polycentric study in double blind].
    Botte L; Bienfait J; Dethier J; Even P; Evrard JL; Fraipont J; Goffin L; Willemse P
    Acta Psychiatr Belg; 1981; 81(6):595-608. PubMed ID: 6125089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buspirone and diazepam in anxiety: a controlled study.
    Rickels K; Weisman K; Norstad N; Singer M; Stoltz D; Brown A; Danton J
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):81-6. PubMed ID: 6130078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alprazolam and amitryptyline: a double blind comparison of anxiolytic and anti-depressant activity.
    Draper RJ; Daly I
    Ir Med J; 1983 Nov; 76(11):453-6. PubMed ID: 6139353
    [No Abstract]   [Full Text] [Related]  

  • 31. Alpidem, a novel anxiolytic drug. A double-blind, placebo-controlled study in anxious outpatients.
    Bassi S; Albizzati MG; Ferrarese C; Frattola L; Cesana B; Piolti R; Farolfi A
    Clin Neuropharmacol; 1989 Feb; 12(1):67-74. PubMed ID: 2565767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind comparison of ketazolam, diazepam and placebo in once-a-day vs t.i.d. dosing.
    Anhalt HS; Young R; Roginsky M
    J Clin Psychiatry; 1980 Nov; 41(11):386-92. PubMed ID: 6108319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential double blind controlled trial of opipramol in anxiety neurosis.
    Carney MW; Maxwell C
    Int J Neuropsychiatry; 1967 Dec; 3(6):491-3. PubMed ID: 4868300
    [No Abstract]   [Full Text] [Related]  

  • 35. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings: Lorazepam in the treatment of neurosis--an uncontrolled clinical study.
    Ananth V; Beszterczy A; Geagea C
    Psychopharmacol Bull; 1976 Jan; 12(1):19-21. PubMed ID: 1825
    [No Abstract]   [Full Text] [Related]  

  • 37. Nonbenzodiazepine anxiolytics: clinical usefulness.
    Rickels K
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):38-44. PubMed ID: 6139368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early morning insomnia and daytime anxiety--a multicentre general practice study comparing loprazolam and triazolam.
    Moon CA; Ankier SI; Hayes G
    Br J Clin Pract; 1985 Sep; 39(9):352-8. PubMed ID: 2865963
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bromazepam(Lexotan) and chlorprothixene(Taractan) in psychoneurotic anxiety states. A randomized, double-blind study from general practice concerning the effect, drug consumption, and risk of repeated treatment].
    Fynboe C; Christensen N; Halberg T; Hansen EA; Holm P; Knudsen JP; Lindhardt J; Maul B; Musaeus C; Nielsen MT; Schaumburg E
    Ugeskr Laeger; 1981 Oct; 143(41):2641-5. PubMed ID: 6117963
    [No Abstract]   [Full Text] [Related]  

  • 40. Observations with tofisopam (grandaxin) treatment in children's diseases.
    Szórády I; Borsodi A
    Ther Hung; 1983; 31(4):172-5. PubMed ID: 6152818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.